Scarlet fever’s rash is written by bacterial toxins from a virus
Scarlet fever follows a minority of strep throat or skin infections with Streptococcus pyogenes. The sandpaper rash is not from the bacterium alone: strains need bacteriophages—especially phage T12—to make pyrogenic exotoxins that damage capillaries and flush the skin.
The illness mainly hits children and adolescents aged five to fifteen. Sudden sore throat, fever, malaise, headache, nausea, vomiting, or abdominal pain can precede a diffuse blanching red rash by one or two days (sometimes before illness or up to a week later). Cheeks flush with a pale ring around the mouth; pastia lines darken skin folds; palms and soles stay clear. A "white strawberry tongue" sheds to a red bumpy tongue after several days. On darker skin the rash may be harder to see, with larger bumps and sandpaper texture. Peeling fingers and toes can follow for weeks and sometimes are the only clue. Cough, runny nose, diarrhea, and conjunctivitis usually point away from scarlet fever toward viruses. Throat culture confirms diagnosis. About one in ten children with group A strep pharyngitis develops scarlet fever; close contacts of strep throat have roughly a 35% chance of infection.
There is no vaccine. Handwashing, not sharing personal items, and staying apart while sick reduce spread via coughs, sneezes, or contaminated objects touched to mouth or nose. Antibiotics shorten symptoms and contagion and prevent most complications; untreated outcomes once included kidney disease, rheumatic fever, and arthritis. In the early twentieth century scarlet fever led childhood death lists, yet severity was already falling before antibiotics—living conditions, control measures, or weaker strains may explain that. Recent decades brought resistance concerns and outbreaks (Hong Kong 2011, UK 2014), with UK occurrence up 68% between 2014 and 2018. October 2020 research linked infection of the bacterium by three viruses to more virulent strains.
Exotoxins SPE A, B, C, and F act as superantigens that broadly activate immune cells; antibodies protect only against the toxin subset encountered, and a dozen pyrogenic exotoxins exist. SPE A, often phage-borne, links most strongly to immune sequelae such as acute rheumatic fever and post-streptococcal glomerulonephritis. Suppurative complications can spread locally (abscesses, mastoiditis, sinusitis) or via blood and lymph (endocarditis, pneumonia, meningitis). Nonsuppurative autoimmune follow-ons include rheumatic heart disease—often mitral stenosis—glomerulonephritis one to two weeks after pharyngitis or after skin strep, and isolated poststreptococcal reactive arthritis. Molecular mimicry lets anti-strep antibodies attack host tissues. Treated, uncomplicated recovery of fever and core symptoms usually occurs in five to ten days before lingering desquamation.
Source: Scarlet fever
